Atopic dermatitis in young children: efficacy and safety of topical anti-inflammatory therapy
https://doi.org/10.21518/2079-701X-2015-14-77-80
Abstract
Atopic dermatitis in children is one of the most common allergic diseases. Topical corticosteroids (tGCS) with anti-inflammatory and antipruritic effect are the core of pathogenetic therapy of atopic dermatitis. The efficiency concept of tGCS is interrelated with the concept of safety, given that the these drugs are not without side effects. This is especially important in case of long-term therapy. The questions of rational use of tGCS in pediatric patients that achieve the maximum therapeutic effect are considered in the article. The high efficiency and safety of long-term therapy with tGCS for atopic dermatitis, including in young children, is demonstrated.
References
1. Кау J, Gawkrodger DJ, Mortimer MJ, Jaron AG. The prevalence of childhood atopic eczema in a general population. J Am Acad Dermatol, 1994. 30: 35-39.
2. Детская аллергология. Руководство для врачей. Под ред. акад. РАМН А.А. Баранова, чл.-корр. РАМН И.И. Балаболкина. М., 2006.
3. Spergel JM. Epidemiology of atopic dermatitis and atopic march in children. Immunol Allergy Clin North Am, 2010. 30: 269-80.
4. Lewis Jones S. Quality of life and childhood atopic dermatitis: the mistery of living with childhood eczema. Int J Clin Pract, 2006. 60: 984-92.
5. Su JC, Kemp FS, Varigos GA et al. Atopic eczema: its impact on the family and financial cost. Arch. Dis. Child, 1997. 76: 159-62.
6. Schmitt J, Romanos M, Pfenning A, Leopold K, Meurer M. Psychiatric comorbidity in adult eczema. Br J Dermatol, 2009. 161: 878-83.
7. Ong PY, Leung DY. Immune dysregulation in atopic dermatitis. Curr AllergyAstma Rep, 2006. 6(5): 384-89.
8. Griffiths WAD, Wilkinson JD. Topicaltherapy. In: Rook, Wilkinson, Ebling Textbook of Dermatology. Eds. R.H. Champion, J.L. Barton, FJ.G. Ebling. London: Blackwell Scientific 1992. 3037-3084.
9. Miller JA, Munro DD. Topical corticosteroids: clinical pharmacology and therapeutic use. Drugs, 1980. 19: 119-34.
10. Akdis С. Review article. Diagnoses and treatment of atopic dermatitis in children and adults. European Academy of Allergology and Clinical Immunology. American Academy of Allergy, Asthma and Immunology. PRACTALL Consensus report. Allergy, 2006. 61: 969-87.
11. Wollenberg A, Bieber T. Proactive therapy of atopic dermatitis - an emerging concept. Allergy,. 2009. 64: 276-78.
12. Ларькова И.А. Рациональная наружная терапия атопического дерматита у детей: в помощь практическому врачу. Consilium medi-cum, 2008. 2: 53-7.
13. GarciaPonte L, Ebert U. Frontiers of rapid itch relief: are view of methylprednisolone aceponate. J Eur Acad Dermatol Venereol, 2012. 26(6): 9-13.
14. Niedner R, Zaumseil RP. Advantan milk/cream/ ointment in children with atopic eczema and other dermatoses: an observational study in 558 children. Akt Dermatol, 2004. 30: 200-03.
15. Luger TA. Balancing efficacy and safety in the management of atopic dermatitis: the role of methylprednisolone aceponate. J Eur Acad Dermatol Venereol, 2011. 25: 251-58.
16. Metz M, Wahn U, Stock P, Schmitt J, Blume-Peytavi U. Chronic pruritus associated with dermatologic disease in infancy and childhood: update from interdisciplinary group of dermatologist and pediatricians. Pediatric Allergy and Immunology, 2013. 24: 527-39.
17. Ларькова И.А., Ксензова Л.Д. Тактика наружной противовоспалительной терапии атопи-ческого дерматита у детей и подростков. Consilium medicum, 2014. 3: 4-8.
Review
For citations:
Larkova IA. Atopic dermatitis in young children: efficacy and safety of topical anti-inflammatory therapy. Meditsinskiy sovet = Medical Council. 2015;(14):77-80. (In Russ.) https://doi.org/10.21518/2079-701X-2015-14-77-80
Views:
584
Email this article 